NO20055243L - Interferon beta ved alvorlig akutt respiratorisk syndrom (SARS) - Google Patents

Interferon beta ved alvorlig akutt respiratorisk syndrom (SARS)

Info

Publication number
NO20055243L
NO20055243L NO20055243A NO20055243A NO20055243L NO 20055243 L NO20055243 L NO 20055243L NO 20055243 A NO20055243 A NO 20055243A NO 20055243 A NO20055243 A NO 20055243A NO 20055243 L NO20055243 L NO 20055243L
Authority
NO
Norway
Prior art keywords
sars
acute respiratory
respiratory syndrome
severe acute
interferon beta
Prior art date
Application number
NO20055243A
Other languages
English (en)
Norwegian (no)
Inventor
Giampiero De Luca
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20055243L publication Critical patent/NO20055243L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20055243A 2003-04-17 2005-11-08 Interferon beta ved alvorlig akutt respiratorisk syndrom (SARS) NO20055243L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03101066 2003-04-17
PCT/EP2004/050456 WO2004091653A1 (en) 2003-04-17 2004-04-06 Interferon beta in severe acute respiratory syndrome (sars)

Publications (1)

Publication Number Publication Date
NO20055243L true NO20055243L (no) 2005-11-08

Family

ID=33185950

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055243A NO20055243L (no) 2003-04-17 2005-11-08 Interferon beta ved alvorlig akutt respiratorisk syndrom (SARS)

Country Status (13)

Country Link
US (1) US20070026014A1 (pt)
EP (1) EP1613342A1 (pt)
JP (1) JP2006523655A (pt)
KR (1) KR20050112127A (pt)
CN (1) CN1798572A (pt)
AU (1) AU2004229185A1 (pt)
BR (1) BRPI0409484A (pt)
CA (1) CA2521650A1 (pt)
EA (1) EA008766B1 (pt)
MX (1) MXPA05011170A (pt)
NO (1) NO20055243L (pt)
UA (1) UA81481C2 (pt)
WO (1) WO2004091653A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2520148A1 (en) * 2003-04-01 2004-12-23 Intermune, Inc. Compositions and methods for treating coronavirus infection and sars
EP1641485A4 (en) * 2003-06-09 2009-06-24 Genome Inst Of Singapore INHIBITION OF SARS CORONAVIRUS INFECTION USING ANTIVIRAL DRUGS CLINICALLY TESTED
US9295669B2 (en) 2010-12-14 2016-03-29 Hoffman La-Roche Inc. Combination therapy for proliferative disorders
CN115867288A (zh) * 2020-03-27 2023-03-28 维克多瑞有限公司 用于治疗呼吸系统病症的组合物
US20220125661A1 (en) * 2020-10-22 2022-04-28 Jacob Waterman Patient-Worn Therapeutic Apparatus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
ES2172288T3 (es) * 1998-05-15 2002-09-16 Schering Corp Terapia de combinacion que comprende ribavirina e interferon alfa en pacientes que no han sido sometidos a tratamiento antiviral y que tienen infeccion cronica de hepatitis c.
JP2002220343A (ja) * 2001-01-26 2002-08-09 Toray Ind Inc びまん性肺疾患延命剤
WO2003031587A2 (en) * 2001-10-09 2003-04-17 The Regents Of The University Of California Use of stat-6 inhibitors as therapeutic agents
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections
US20050137154A1 (en) * 2003-05-16 2005-06-23 Hemispherx Biopharma Treating server acute respiratory syndrome

Also Published As

Publication number Publication date
EA200501625A1 (ru) 2006-04-28
CN1798572A (zh) 2006-07-05
EA008766B1 (ru) 2007-08-31
US20070026014A1 (en) 2007-02-01
UA81481C2 (en) 2008-01-10
WO2004091653A1 (en) 2004-10-28
BRPI0409484A (pt) 2006-05-02
AU2004229185A1 (en) 2004-10-28
JP2006523655A (ja) 2006-10-19
KR20050112127A (ko) 2005-11-29
CA2521650A1 (en) 2004-10-28
EP1613342A1 (en) 2006-01-11
MXPA05011170A (es) 2005-12-14

Similar Documents

Publication Publication Date Title
EE05065B1 (et) Karbamiidasendatud imidasokinoliinid, nende kasutamine raviks ja neid sisaldavad farmatseutilised preparaadid
TW200733953A (en) Materials and methods for treating viral infections
NO20006328D0 (no) Attenuerte negative trådvirus med endret interferonantagonistaktivitet for anvendelse som vaksiner og medikamenter
NO20073632L (no) Behandling av hepatitt C med interferon-beta i en asiatisk populasjon
NO20065860L (no) Stabiliserte flytende interferonformuleringer
ATE476983T1 (de) Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen der atemwege
BR0011433B1 (pt) Compostos de imidazoquinolinas substituídas com sulfonamida e sulfamida e composição farmaceutica cotendo os mesmos
HUP0103423A2 (hu) Ribavirint és alfa-interferont tartalmazó kombinált terápia vírusellenes kezelésben nem részesült, krónikus hepatitis C fertőzött paciensek kezelésében
NO20061912L (no) Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system
WO2005023290A3 (en) Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections
PL371736A1 (en) Method for administering glp-1 molecules
NO20055243L (no) Interferon beta ved alvorlig akutt respiratorisk syndrom (SARS)
TW200633995A (en) Andrographolide derivatives to treat viral infections
NO20053348L (no) Farmasoytisk sammensetning for behandling av virusangrep.
HUP0202502A2 (hu) Virális fertőzőképességet blokkoló peptidek és eljárások ezek alkalmazására
DK1423168T3 (da) Farmaceutisk præparat omfattende gabapentin eller en analog deraf og et alfa-aminoamid og dets analgetiske anvendelse
EP1624850A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS)
ATE546151T1 (de) Verwendung von hcg-fragmente enthaltene zusammensetzungen zur mukosalen und oralen anwendung
WO2007057436A3 (en) Interferon in influenza
NO20055512L (no) Terapi eller prevensjon av respiratoriske, virale infeksjoner med alfa-tyimosinpeptider
WO2004089983A3 (en) Severe acute respiratory syndrome (sars) causing coronavirus
BR9916893A (pt) Tratamento
NO20035056D0 (no) Adenosinanaloger for behandling av insulinresistenssyndrom og diabetes
HUP0202931A2 (hu) Egy gyógyszerészetileg hatásos összetétel és a beadására szolgáló készülék
HUP0402299A2 (hu) Ámbroxolt és brómhexint tartalmazó influenza elleni készítmény és eljárás az előállítására

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application